Stifel raises TransMedics Group target price to $70 from $65
TMDX•Stifel raised its target price for TransMedics Group to $70 from $65.
Related News
Vistra Q3 revenue and adjusted EBITDA beat estimates on higher energy, capacity prices
VST•
10X Genomics target price cut to $50 from $70 by Deutsche Bank
TXG•
Microchip Technology: Rosenblatt Securities cuts target price to $115 from $120
MCHP•
Texas Roadhouse target price raised to $210 from $200 by Deutsche Bank
TXRH•
Brookfield Asset Management Q3 fee-related earnings rise on Oaktree acquisition
BAM•